Broad Institute   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Cambridge MA United States (2004)

Organization Overview

First Clinical Trial
2008
NCT01762046
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Broad Institute